A 62-year-old man underwent pancreaticoduodenectomy with modified Child reconstruction for a ducttype intraductal papillary mucinous neoplasm localized at the pancreatic head. One year later, he was admitted because of pancreatitis associated with pancreaticojejunostomy stricture (PJS). We performed ERCP with a small-caliber colonoscope, successfully identified the anastomosis, and cannulated the pancreatic duct. Then, we dilated the PJS using a balloon catheter and deployed a 5F plastic stent. However, 2 months after ERCP, the patient experienced upper-abdominal discomfort, and laboratory test results showed elevated serum pancreatic enzymes.
Written transcript of the video audio is available online at www.VideoGIE.org. Tokyo, Japan) (Video 1, available online at www. VideoGIE.org). We were able to advance the echoendoscope to the anastomosis site and identify the pancreatic duct on EUS (Fig. 3) . We punctured the pancreatic duct with a 19-gauge needle (EZ Shot 3 Plus, Olympus) and performed pancreatography with injection of contrast medium (Fig. 4) . Next, we inserted a 0.025-inch guidewire (VisiGlide 2, Olympus) into the pancreatic duct through the needle.
We dilated the puncture site in a stepwise fashion with a 4F tapered catheter (PR-110Q, Olympus) and a dilation catheter (ES Dilator; Zeon Medical, Tokyo, Japan) (Fig. 5) . Finally, we deployed a 7F plastic stent (Advanix Pancreatic Stent, NaviFlex RX Pancreatic Delivery System; Boston Scientific, Natick, Mass) across the puncture site (Fig. 6) . No adverse events related to the procedure were noted. At 5 months after treatment, the patient remained symptom free, and CT showed no sign of recurrence.
In this case, we successfully performed EUS-guided retrograde pancreatic stent placement for refractory PJS using an FV echoendoscope. Despite the advances in endoscopic techniques and devices, the endoscopic treatment of PJS remains technically challenging because of the length of the afferent limb, difficulties in detecting small anastomotic sites, and difficulties in cannulating the pancreatic duct through severe strictures.
Recently, EUS-guided pancreatic duct drainage (EUS-PDD) has been developed and reported to be superior to enteroscopy-assisted ERCP.
1,2 However, EUS-PDD, which includes a rendezvous technique and antegrade stent placement through a pancreaticogastrostomy, is a transgastric technique, is performed through the abdominal cavity, and carries the risk of pancreatic juice leakage. In fact, adverse events are more commonly associated with EUS-PDD than with enteroscopy-assisted ERCP. 2 To our knowledge, only 2 other reports have demonstrated successful EUS-guided retrograde stent placement for PJS. 3, 4 The advantages of this technique are that it is a 1-step procedure, and it is not performed through the abdominal cavity. Thus, this technique may be preferable to EUS-PDD in terms of adverse events. 
